Intranasal immunogenicity of a Δcya Δcrp-pab A mutant of Salmonella enterica serotype Typhimurium for the horse

Vaccine

Volumn 19, Issue 27, 2001, Pages 3787-3795

  Sheoran, Abhineet S ^a   Timoney, John F ^a   Tinge, Steven A ^b   Sundaram, Preeti ^b   Curtiss III, Roy ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Megan Health Inc   (United States)

Author keywords

Antibody isotype; Horse; Intranasal; Nasal mucosal; Salmonella enterica serotype Typhimurium

Indexed keywords

ALLOANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN SUBCLASS; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; FECES ANALYSIS; HORSE; HORSE DISEASE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; JEJUNUM MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; SPECIES DIFFERENCE; VAGINA MUCOSA;

ADENYLATE CYCLASE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CYCLIC AMP RECEPTOR PROTEIN; FECES; FEMALE; GENE DELETION; HORSES; IMMUNIZATION SCHEDULE; MUTATION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPING; VACCINES, ATTENUATED;

EID: 0035859280     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00091-3     Document Type: Article

References (44)

1. Equine salmonellosis: A contemporary view
2. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches
3. Salmonella typhimurium infection in calves: Cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines
4. The common mucosal immune system and current strategies for induction of immune response in external secretions
5. Humoral responses and salmonellosis protection in chickens given a vitamin-dependent Salmonella typhimurium mutant
6. Differences in the immune responses of mice and sheep to an aromatic-dependent mutant of Salmonella typhimurium
7. Aromatic dependent Salmonella typhimurium are nonvirulent and effective as live vaccines
8. Vaccination of chickens with chicken-derived Salmonella enteritidis phage type 4 aroA live oral Salmonella vaccines
9. Vaccination of calves with orally administered aromatic-dependent Salmonella dublin
10. The effect of exposure to a Δcya Δcrp mutant of Salmonella typhimurium on the subsequent colonization of swine by the wild type parent strain
11. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic
12. Virulence and vaccine potential of pho P mutants of Salmonella typhimurium
13. Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes
14. A two-component regulatory system (pho P pho Q) controls Salmonella typhimurium virulence
15. Attenuation and immunogenicity of Δcya Δcrp derivatives of Salmonella choleraesuis in pigs
16. Analysis of sequence elements important for expression and regulation of the adenylate cyclase gene (cya) of Salmonella typhimurium
17. A novel suicide vector and its use in construction of insertion mutations: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR
18. Genetic engineering in vivo using translocatable drug-resistance elements
19. Selection for loss of tetracycline resistance by Escherichia coli
20. crp genes of Shigella flexneri, Salmonella typhimurium and Escherichia coli
21. Evolution of glutamine amidotransferase genes. Nucleotide sequences of the pab A genes from Salmonella typhimurium, Klebsiella aerogenes and Serratia marcescens
22. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses
23. Monoclonal antibodies to subclass-specific antigenic determinants on equine immunoglobulin gamma chains and their characterization
24. Production of monoclonal antibodies to six isotypes of horse immunoglobulin
25. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei
26. Further characterization of Δaro A, Δvir G Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli
27. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits
28. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization
29. Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine
30. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis
31. Technical report: Results of immunological tests on faecal extracts are likely to be extremely misleading
32. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination
33. Quantitation of the immunoglobulins in reproductive tract secretions of the mare
34. The route of enteric infection in normal mice
35. M cells and associated lymphoid tissue of the equine nasopharyngeal tonsil
36. The role of nasopharyngeal lymphoid tissue
37. Nasal lymphoid tissue in the rat
38. Molecular and cellular basis of immune protection of mucosal surfaces
39. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors
40. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues
41. Monoclonal antibodies to Salmonella lipopolysaccharide: Anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium
42. Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium
43. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells
44. T-cell independent human pneumococcal polysaccharide antibody synthesis